261 related articles for article (PubMed ID: 9425940)
1. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.
Ghany MG; Ayola B; Villamil FG; Gish RG; Rojter S; Vierling JM; Lok AS
Hepatology; 1998 Jan; 27(1):213-22. PubMed ID: 9425940
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.
Protzer-Knolle U; Naumann U; Bartenschlager R; Berg T; Hopf U; Meyer zum Büschenfelde KH; Neuhaus P; Gerken G
Hepatology; 1998 Jan; 27(1):254-63. PubMed ID: 9425945
[TBL] [Abstract][Full Text] [Related]
3. Liver graft infection by HBV S-gene mutants in transplant patients receiving long-term HBIg prophylaxis.
Santantonio T; Gunther S; Sterneck M; Rendina M; Messner M; Launois B; Francavilla A; Pastore G; Will H
Hepatogastroenterology; 1999; 46(27):1848-54. PubMed ID: 10430358
[TBL] [Abstract][Full Text] [Related]
4. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
Tabor E
J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
[TBL] [Abstract][Full Text] [Related]
5. Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation.
Grottola A; Buttafoco P; Del Buono MG; Cremonini C; Colantoni A; Gelmini R; Morelli C; Masetti M; Jovine E; Fruet F; Pinna A; Manenti F; Villa E
Liver Transpl; 2002 May; 8(5):443-8. PubMed ID: 12004344
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
[TBL] [Abstract][Full Text] [Related]
7. [A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
Song HL; Shen ZY; Wang J; Zheng WP; Wang ZL
Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):265-9. PubMed ID: 18423147
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus mutations in the pre-S genome before and after liver transplantation.
Trautwein C; Schrem H; Tillmann HL; Kubicka S; Walker D; Böker KH; Maschek HJ; Pichlmayr R; Manns MP
Hepatology; 1996 Sep; 24(3):482-8. PubMed ID: 8781311
[TBL] [Abstract][Full Text] [Related]
9. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.
Carman WF; Trautwein C; van Deursen FJ; Colman K; Dornan E; McIntyre G; Waters J; Kliem V; Müller R; Thomas HC; Manns MP
Hepatology; 1996 Sep; 24(3):489-93. PubMed ID: 8781312
[TBL] [Abstract][Full Text] [Related]
11. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
[TBL] [Abstract][Full Text] [Related]
12. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
[TBL] [Abstract][Full Text] [Related]
13. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change.
Ren F; Tsubota A; Hirokawa T; Kumada H; Yang Z; Tanaka H
Gene; 2006 Nov; 383():43-51. PubMed ID: 16963200
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of de novo hepatitis B infection after pediatric liver transplantation.
Su WJ; Ho MC; Ni YH; Wu JF; Jeng YM; Chen HL; Wu YM; Hu RH; Chang MH; Lee PH
Liver Transpl; 2010 Feb; 16(2):215-21. PubMed ID: 20104496
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
17. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
[TBL] [Abstract][Full Text] [Related]
18. Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India.
Banerjee A; Chandra PK; Datta S; Biswas A; Bhattacharya P; Chakraborty S; Chakrabarti S; Bhattacharya SK; Chakravarty R
J Clin Virol; 2007 Dec; 40(4):312-7. PubMed ID: 17997353
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
[TBL] [Abstract][Full Text] [Related]
20. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen.
Shinji T; Koide N; Hanafusa T; Hada H; Oka T; Takayama N; Shiraha H; Nakamura M; Ujike K; Yumoto Y; Tsuji T
Hepatogastroenterology; 1998; 45(20):500-2. PubMed ID: 9638436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
